Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Registry of Sarcoidosis Associated Pulmonary Hypertension (RESAPH) (RESAPH)

This study is currently recruiting participants. (see Contacts and Locations)
Verified December 2015 by University of Cincinnati
The Cleveland Clinic
Information provided by (Responsible Party):
Robert P Baughman, University of Cincinnati Identifier:
First received: November 4, 2011
Last updated: December 4, 2015
Last verified: December 2015
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: January 2018
  Estimated Primary Completion Date: January 2017 (Final data collection date for primary outcome measure)